![Tomasz Franciszek Baran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomasz Franciszek Baran
Directeur Technique/Scientifique/R&D chez
FAMICORD AG
Fortune : 523 762 $ au 30/06/2026
Profil
Tomasz Franciszek Baran is Vice Chairman-Management Board at Polski Bank Komorek Macierzystych SA since 2020, Director at Stemlab SA, and Chief Medical Officer at FamiCord AG starting in 2025.
Former roles include Chief Executive Officer at FamiCordTX SA, Manager-Regional Sales & Product at Pliva Krakow Sa from 1998 to 2004, Manager-Marketing & Group Manager-Product at AstraZeneca Pharma Poland Sp zoo from 2004 to 2008, Marketing Manager at Stiefel Polska SP zoo from 2008 to 2009, and Marketing Manager at GlaxoSmithKline Pharmaceuticals SA. Education includes an MBA from the University of Quebec and Warsaw School of Economics in 2007, and an undergraduate degree from Medical University of Lublin in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FAMICORD AG 0,7% | 31/12/2024 | 123 481 ( 0,7% ) | 523 762 $ | 30/06/2026 |
Postes actifs de Tomasz Franciszek Baran
| Sociétés | Poste | Début |
|---|---|---|
| POLI BANK | Corporate Officer/Principal | 01/01/2012 |
| FAMICORD AG | Directeur Technique/Scientifique/R&D | 01/03/2025 |
Stemlab SA
 Stemlab SA BiotechnologyHealth Technology Provides umbilical cord stem cell isolation and cryopreservation | Directeur/Membre du Conseil | - |
Anciens postes connus de Tomasz Franciszek Baran
| Sociétés | Poste | Fin |
|---|---|---|
Stiefel Polska SP zoo | Corporate Officer/Principal | 01/01/2009 |
AstraZeneca Pharma Poland Sp zoo
 AstraZeneca Pharma Poland Sp zoo Pharmaceuticals: MajorHealth Technology Develop and produces medicines that fight diseases | Sales & Marketing | 01/01/2008 |
Pliva Krakow Sa
 Pliva Krakow Sa Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Sales & Marketing | 01/01/2004 |
Famicordtx SA | Directeur Général | - |
Glaxosmithkline Pharmaceuticals SA
 Glaxosmithkline Pharmaceuticals SA Pharmaceuticals: GenericHealth Technology Manufactures drugs and vaccines | Sales & Marketing | - |
Formation de Tomasz Franciszek Baran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Pliva Krakow Sa
Pliva Krakow Sa Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Quebec
 University of Quebec Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warsaw School of Economics
 Warsaw School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stemlab SA
Stemlab SA BiotechnologyHealth Technology Provides umbilical cord stem cell isolation and cryopreservation | Health Technology |
Polski Bank Komorek Macierzystych SA
 Polski Bank Komorek Macierzystych SA Medical/Nursing ServicesHealth Services Operates as a stem cell bank | Health Services |
AstraZeneca Pharma Poland Sp zoo
AstraZeneca Pharma Poland Sp zoo Pharmaceuticals: MajorHealth Technology Develop and produces medicines that fight diseases | Health Technology |
Stiefel Polska SP zoo | |
Glaxosmithkline Pharmaceuticals SA
Glaxosmithkline Pharmaceuticals SA Pharmaceuticals: GenericHealth Technology Manufactures drugs and vaccines | Health Technology |
Vita 34 AG
 Vita 34 AG BiotechnologyHealth Technology Provides umbilical stem cell preservation and cord blood-banking services | Health Technology |
Medical University of Lublin
 Medical University of Lublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Famicordtx SA |
Choisissez Zonebourse 
